NASDAQ : ANDA

Andina Acquisition Corp. III — News

$9.2 USD

$0.3 (3.37%)

Volume
314.28K
Average Volume
30.34K
Market Capitalization
$335.92M
P/E Ratio
0.00
Dividend Yield
0.00%
Price Target
$6.00
Year High
$14.00
Year Low
$8.70
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.00
Source Headline
Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection

Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection PR Newswire MUMBAI, India and NAP

gurufocus.com - 2026-06-03 04:00:00

Get ANDA Insider Trade Alerts

ANDA Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$0.00

0 analysts

All Time

$6.00

1 analysts

ANDA Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade